Castle Biosciences, Inc. (CSTL)
28.17
+0.60
(+2.18%)
USD |
NASDAQ |
Mar 04, 16:00
28.19
+0.02
(+0.07%)
After-Hours: 20:00
Castle Biosciences Cash from Investing (TTM) : -60.37M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | -34.32M |
| Delcath Systems, Inc. | -26.59M |
| Assertio Holdings, Inc. | -12.57M |
| CorMedix, Inc. | -312.03M |
| Harmony Biosciences Holdings, Inc. | -39.65M |